Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Freeline Therapeutics

    NASDAQ: FRLN · Real-Time Price · USD
    6.49
    0.01 (0.15%)
    At close: Feb 16, 2024, 9:37 PM

    Freeline Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 47.28M 117.66M
    Short-Term Investments
    		 n/a n/a
    Long-Term Investments
    		 1.33M -377K
    Other Long-Term Assets
    		 3.46M 2.92M
    Receivables
    		 1.23M 2.21M
    Inventory
    		 17.64M 6.42M
    Other Current Assets
    		 1.47M 2M
    Total Current Assets
    		 67.63M 128.29M
    Property-Plant & Equipment
    		 15.02M 9.91M
    Goodwill & Intangibles
    		 -1.33M 8K
    Total Long-Term Assets
    		 19.01M 12.83M
    Total Assets
    		 86.64M 141.13M
    Account Payables
    		 10.06M 5.19M
    Deferred Revenue
    		 n/a n/a
    Short-Term Debt
    		 2.66M n/a
    Other Current Liabilities
    		 18.25M 15.5M
    Total Current Liabilities
    		 30.97M 20.68M
    Long-Term Debt
    		 3.26M n/a
    Other Long-Term Liabilities
    		 n/a n/a
    Total Long-Term Liabilities
    		 3.26M n/a
    Total Liabilities
    		 34.23M 20.68M
    Total Debt
    		 5.92M n/a
    Common Stock
    		 137K 137K
    Retained Earnings
    		 -445.35M -356.38M
    Comprehensive Income
    		 -3.15M 9.47M
    Shareholders Equity
    		 52.41M 120.44M
    Total Investments
    		 1.33M -377K

    Add to Watchlist